Heart Failure-Complicating Acute Myocardial Infarction

Heart Failure Clinics

Volumn 3, Issue 4, 2007, Pages 465-475

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL; MILRINONE; MORPHINE; PLACEBO; RAMIPRIL; TIMOLOL; VERAPAMIL;

ACUTE HEART INFARCTION; ARTERIAL OXYGEN SATURATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LUNG CONGESTION; LUNG EDEMA; MEAN ARTERIAL PRESSURE; MORTALITY; OXYGEN THERAPY; PULMONARY HYPERTENSION; REVIEW; TREATMENT CONTRAINDICATION; VASCULAR RESISTANCE;

EID: 34748861843     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.07.010     Document Type: Review

References (105)

1. Aronow W.S. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients. Heart Dis 5 (2003) 279-294
2. Aronow W.S., Ahn C., and Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 113 (1998) 867-869
3. Aronow W.S., and Ahn C. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus. Chest 115 (1999) 867-868
4. Aronow W.S., Ahn C., and Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 84 (1999) 611-612
5. Rich M.W., Bosner M.S., Chung M.K., et al. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?. Am J Med 92 (1992) 7-13
6. Bueno H., Vidan M.T., Almazan A., et al. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation 92 (1995) 1133-1140
7. Kober L., Torp-Pedersen C., Ottesen M., et al. Influence of gender on short- and long-term mortality after acute myocardial infarction. Am J Cardiol 77 (1996) 1052-1056
8. Weaver W.D., White H.D., Wilcox R.G., et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 275 (1996) 777-782
9. Aronow W.S. Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients. Am J Cardiol 60 (1987) 1182
10. Wolk M.J., Scheidt S., and Killip T. Heart failure complicating acute myocardial infarction. Circulation 45 (1972) 1125-1138
11. Dwyer Jr. E.M., Greenberg H.M., Steinberg G., et al. Clinical characteristics and natural history of survivors of pulmonary congestion during acute myocardial infarction. Am J Cardiol 63 (1989) 1423-1428
12. Gottlieb S., Moss A.J., McDermott M., et al. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction. Am J Cardiol 69 (1992) 977-984
13. Forrester J., Diamond G., Chatterjee K., et al. Medical therapy of acute myocardial infarction by the application of hemodynamic subsets. N Engl J Med 295 (1976) 1356-1362
14. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico: GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343 (1994) 1115-1122
15. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 66 (1990) 1257-1259
16. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol 85 (2000) 1382-1384
17. Aronow W.S. Treatment of systolic and diastolic heart failure in elderly persons. J Gerontol: Med Sci 60A (2006) 1597-1605
18. Rich M.W. Therapy of acute myocardial infarction. In: Aronow W.S., and Fleg J.L. (Eds). Cardiovascular disease in the elderly. 3rd edition (2004), Marcel Dekker, New York 297-327
19. Aronow W.S. Echo in the elderly. Cardio 8 (1990) 81-90
20. Harrison M.R., MacPhail B., Gurley J.C., et al. Usefulness of color Doppler flow imaging to distinguish ventricular septal defect from acute mitral regurgitation complicating acute myocardial infarction. Am J Cardiol 64 (1989) 697-701
21. Butman S., Olson H.G., and Aronow W.S. Remote right ventricular infarction mimicking pericardial constriction. Am Heart J 103 (1982) 912-914
22. Smyllie J.H., Sutherland G.R., Geuskens R., et al. Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation after myocardial infarction. J Am Coll Cardiol 15 (1990) 1449-1455
23. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol 44 (2004) 671-719
24. Maroko P.R., Radvany P., Braunwald E., et al. Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation 52 (1975) 360-368
25. Fillmore S.J., Shapiro M., and Killip T. Arterial oxygen tension in acute myocardial infarction: serial analysis of clinical state and blood gas changes. Am Heart J 79 (1970) 620-629
26. Aubier M., Trippenbach T., and Roussos C. Respiratory muscle fatigue during cardiogenic shock. J Appl Physiol 51 (1981) 499-508
27. Hyzy R., and Popovich J. Mechanical ventilation and weaning. In: Carlson R.W., and Geheb M.A. (Eds). Principles and practice of medical intensive care (1993), WB Saunders, Philadelphia 924-933
28. Zelis R., Mansour E.J., Capone R.J., et al. The cardiovascular effects of morphine: the peripheral capacitance and resistance vessels in human subjects. J Clin Invest 54 (1974) 1247-1258
29. Vismara L.A., Leaman D.M., and Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 54 (1976) 335-337
30. Butman S., and Aronow W.S. Updated treatment for left ventricular failure and acute cardiogenic pulmonary edema. ER Reports 2 (1981) 53-58
31. Biddle T.L., and Yu P.N. Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction. Am J Cardiol 43 (1973) 86-90
32. Dikshit K., Vyden M.B., Forrester J.S., et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288 (1973) 1087-1090
33. Flaherty J.T. Role of nitrates in acute myocardial infarction. Am J Cardiol 70 (1992) 73B-81B
34. Jugdutt B.I. Role of nitrates after acute myocardial infarction. Am J Cardiol 70 (1992) 82B-87B
35. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345 (1995) 669-685
36. Come P.C., and Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 54 (1976) 624-628
37. Kinch J.W., and Ryan T.J. Right ventricular infarction. N Engl J Med 330 (1994) 1211-1217
38. Gunnar R.M., Lambrew C.T., Abrams W., et al. Task force IV: pharmacologic interventions. Emergency cardiac care. Am J Cardiol 50 (1982) 393-408
39. Swedberg K., Held P., Kjekhus J., et al. Effects of the early administration of enalapril on mortality in patients with myocardial infarction. N Engl J Med 327 (1992) 678-684
40. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 (1991) 303-310
41. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342 (1993) 821-828
42. Ambrosioni E., Borghi C., Magnani B., et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 332 (1995) 80-85
43. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 333 (1995) 1670-1676
44. Lisheng L., Liu L.S., Wang W., et al. Oral captopril versus placebo among 13,364 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 345 (1995) 686-687
45. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico: six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six-weeks after acute myocardial infarction: the GISSI-3 trial. J Am Coll Cardiol 27 (1996) 337-344
46. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 (1992) 669-677
47. Aronow W.S., Ahn C., and Kronzon I. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 88 (2001) 1298-1300
48. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28 (1996) 1328-1428
49. Sigurdsson A., and Swedberg K. Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction. Eur Heart J 15 Suppl B (1994) 14-19
50. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
51. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
52. Aronow W.S., and Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 71 (1993) 602-604
53. Philbin E.F., Rocco Jr. T.A., Lindenmuth N.W., et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 109 (2000) 605-613
54. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. Circulation 112 (2005) 1825-1852
55. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
56. Cohn J.N., and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675
57. Pfeffer M.A., McMurray J.J.V., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
58. Granger C.B., McMurray J.J.V., Yusuf S., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362 (2003) 772-776
59. McMurray J.J.V., Ostergren J., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362 (2003) 767-771
60. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362 (2003) 777-781
61. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
62. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
63. Hjalmarson A., Elmfeldt D., Herlitz J., et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 2 (1981) 823-827
64. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J 6 (1985) 199-226
65. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 2 (1986) 57-66
66. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 83 (1991) 422-437
67. Smith Jr. S.C. Drug treatment after acute myocardial infarction: is treatment the same for the elderly as in the young patient?. Am J Geriatr Cardiol 7 (1998) 60-64
68. Herlitz J., Waagstein F., Lindqvist J., et al. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial). Am J Cardiol 80 (1997) 40J-44J
69. Teo K.K., Yusuf S., and Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 270 (1993) 1589-1595
70. Hansteen V. Beta blockade after myocardial infarction: the Norwegian Propranolol Study in high-risk patients. Circulation 67 suppl I (1983) I-57-I-60
71. Gundersen T., Abrahamsen A.M., Kjekshus J., et al. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation 66 (1982) 1179-1184
72. Pedersen T.R. Six-year follow-up of the Norwegian Multicentre Study on Timolol after acute myocardial infarction. N Engl J Med 313 (1985) 1055-1058
73. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 247 (1982) 1707-1714
74. Park K.C., Forman D.E., and Wei J.Y. Utility of beta-blockade treatment for older postinfarction patients. J Am Geriatr Soc 43 (1995) 751-755
75. Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 73 (1986) 503-510
76. The Beta-Blocker Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomised trials in post-infarction patients. Eur Heart J 9 (1988) 8-16
77. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
78. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
79. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
80. Packer M., Coats A.J.S., Fowler M.B., et al. Effect of carvedilol on survival in chronic heart failure. N Engl J Med 344 (2001) 651-658
81. Aronow W.S., Ahn C., and Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors. Am J Cardiol 80 (1997) 207-209
82. Soumerai S.B., McLaughlin T.J., Spiegelman D., et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 277 (1997) 115-121
83. Yusuf S., Wittes J., and Probstfield J. Evaluating effects of treatment subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers. Am J Cardiol 60 (1990) 220-222
84. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319 (1988) 385-392
85. Goldstein R.E., Boccuzzi S.J., Cruess D., et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83 (1991) 52-60
86. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1321-1326
87. Yusuf S., Held P., and Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 67 (1991) 1295-1297
88. Elkayam U., Amin J., Mehra A., et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 82 (1990) 1954-1961
89. Aronow W.S. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?. Drugs Aging 1 (1991) 98-103
90. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
91. Rich M.W., McSherry F., Williford W.O., et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG Study. J Am Coll Cardiol 38 (2001) 806-813
92. Rich M.W., Woods W.L., Davila-Roman V.G., et al. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure. J Am Geriatr Soc 43 (1995) 271-274
93. Dies F., Krell M.J., Whitlow P., et al. Intermittent dobutamine in ambulatory out-patients with chronic cardiac failure. [abstract]. Circulation 74 suppl II (1986) II-38
94. O'Connor C.M., Gattis W.A., Uretsky B.F., et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138 (2000) 78-86
95. Kennedy H.L., Brooks M.M., Barker A.H., et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 74 (1994) 674-680
96. Aronow W.S., Ahn C., Mercando A.D., et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol 74 (1994) 267-270
97. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 106 (2002) 2145-2161
98. Aronow W.S. Management of the older person with atrial fibrillation. J Gerontol: Med Sci 57A (2002) M352-M363
99. Nunez L., de La Llana R., Lopez Sendon J., et al. Diagnosis of treatment of subacute free wall ventricular rupture after infarction. Ann Thorac Surg 35 (1983) 525-529
100. Labovitz A.J., Miller L.W., and Kennedy H.L. Mechanical complications of acute myocardial infarction. Cardiovasc Rev Rep 5 (1984) 948-952
101. Bolooki H. Surgical treatment of complications of acute myocardial infarction. JAMA 263 (1990) 1237-1240
102. Lemery R., Smith H.C., Giuliani E.R., et al. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 70 (1992) 147-151
103. Aronow W.S. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction. Geriatrics 60 2 (2005) 24-28
104. Cleland J.G.F., Daubert J.-C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
105. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237